Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Cadglib M 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Caddes Life Sciences

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Cadglib M 5mg/500mg Tablet

Metformin/Glimepiride 5mg/500mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation aids in regulating blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a fast-acting sugar source. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring is essential, along with potential blood tests to assess blood cell counts and liver function.

Uses of Cadglib M 5mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Cadglib M 5mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It's recommended to take Cadglib M 5mg/500mg Tablet with a meal.

Common Side effects of Cadglib M 5mg/500mg Tablet:

  • Dizziness
  • Diarrhea
  • Nausea
  • Flatulence
  • Headache
  • Upper respiratory tract infection

How to use Cadglib M 5mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Cadglib M 5mg/500mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Always take this medication with food.

How Cadglib M 5mg/500mg Tablet works:

Glibenclamide, a sulfonylurea drug, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness in peripheral tissues.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Cadglib M 5mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Cadglib M 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

The use of Cadglib M 5mg/500mg tablets requires careful consideration while breastfeeding. Mothers should discontinue breastfeeding for the duration of their treatment with this medication and until its complete elimination from their system.

DrivingDrivingCONSULT YOUR DOCTOR

Cadglib M 5mg/500mg Tablet's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

The use of Cadglib M 5mg/500mg tablets is likely inadvisable for individuals with kidney impairment and should be avoided. Seek medical advice before taking this medication.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Cadglib M 5mg/500mg tablets. Dosage modification may be necessary. Physician consultation is recommended.

What if you forget to take Cadglib M 5mg/500mg Tablet :

Should you forget to take a Cadglib M 5mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Cadglib M 5mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Cadglib M 5mg/500mg Tablet

Cadglib M 5mg/500mg tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, arises from the body's inability to produce sufficient insulin or utilize existing insulin effectively. This leads to elevated blood glucose, causing serious health issues. High blood sugar symptoms include excessive urination, thirst, and hunger. Untreated, type 2 diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased heart disease risk.
Cadglib M 5mg/500mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Cadglib M 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Cadglib M 5mg/500mg Tablets can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, yearly supplemental vitamin B12 is recommended by some researchers.
Cadglib M 5mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Cadglib M 5mg/500mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Cadglib M 5mg/500mg tablets combine glibenclamide and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Diabetes type 2, the most prevalent form of diabetes, arises from insufficient insulin production or ineffective insulin function. This leads to elevated blood glucose, causing serious health issues. High blood sugar symptoms include excessive urination, thirst, and hunger. Untreated, diabetes can result in long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and increased cardiovascular risk.
Cadglib M 5mg/500mg Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Cadglib M 5mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged use of Cadglib M 5mg/500mg Tablet can interfere with vitamin B12 absorption, potentially leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Cadglib M 5mg/500mg Tablets are contraindicated in patients with allergies to any ingredient, those with moderate to severe kidney disease, and those with metabolic acidosis, including diabetic ketoacidosis.
Combining Cadglib M 5mg/500mg Tablet with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Cadglib M 5mg/500mg Table...
23
MRP 27
14% off